205 related articles for article (PubMed ID: 8521296)
1. Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis.
Tramontana JM; Utaipat U; Molloy A; Akarasewi P; Burroughs M; Makonkawkeyoon S; Johnson B; Klausner JD; Rom W; Kaplan G
Mol Med; 1995 May; 1(4):384-97. PubMed ID: 8521296
[TBL] [Abstract][Full Text] [Related]
2. The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection.
Klausner JD; Makonkawkeyoon S; Akarasewi P; Nakata K; Kasinrerk W; Corral L; Dewar RL; Lane HC; Freedman VH; Kaplan G
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Mar; 11(3):247-57. PubMed ID: 8603261
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease.
Bauditz J; Wedel S; Lochs H
Gut; 2002 Feb; 50(2):196-200. PubMed ID: 11788559
[TBL] [Abstract][Full Text] [Related]
4. Cytokine regulation of disease progression in leprosy and tuberculosis.
Kaplan G
Immunobiology; 1994 Oct; 191(4-5):564-8. PubMed ID: 7713571
[TBL] [Abstract][Full Text] [Related]
5. [The effect of interleukin-7 and interleukin-15 on the production of Th1 and Th2 cytokines by peripheral blood mononuclear cells from patients with tuberculosis].
Yang XM; Dong DQ; Li C; Yang YH
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):403-6. PubMed ID: 17045026
[TBL] [Abstract][Full Text] [Related]
6. Novel biological response modifiers derived from thalidomide.
Hashimoto Y
Curr Med Chem; 1998 Jun; 5(3):163-78. PubMed ID: 9562600
[TBL] [Abstract][Full Text] [Related]
7. Effect of TNF-α production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individuals.
Luna T; Santos SB; Nascimento M; Porto MA; Muniz AL; Carvalho EM; Jesus AR
Braz J Med Biol Res; 2011 Nov; 44(11):1134-40. PubMed ID: 22011961
[TBL] [Abstract][Full Text] [Related]
8. Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations.
Pereira CB; Palaci M; Leite OH; Duarte AJ; Benard G
Microbes Infect; 2004 Jan; 6(1):25-33. PubMed ID: 14738890
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide analogue CC1069 inhibits development of rat adjuvant arthritis.
Oliver SJ; Freeman SL; Corral LG; Ocampo CJ; Kaplan G
Clin Exp Immunol; 1999 Nov; 118(2):315-21. PubMed ID: 10540197
[TBL] [Abstract][Full Text] [Related]
10. Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity.
Corral LG; Muller GW; Moreira AL; Chen Y; Wu M; Stirling D; Kaplan G
Mol Med; 1996 Jul; 2(4):506-15. PubMed ID: 8827720
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells.
Shannon EJ; Sandoval F
Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):59-72. PubMed ID: 8683039
[TBL] [Abstract][Full Text] [Related]
12. Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia.
Shannon E; Noveck R; Sandoval F; Kamath B; Kearney M
Transl Res; 2007 Nov; 150(5):275-80. PubMed ID: 17964516
[TBL] [Abstract][Full Text] [Related]
13. Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis.
Bekker LG; Haslett P; Maartens G; Steyn L; Kaplan G
J Infect Dis; 2000 Mar; 181(3):954-65. PubMed ID: 10720518
[TBL] [Abstract][Full Text] [Related]
14. In vitro production of tumour necrosis factor and prostaglandin E2 by peripheral blood mononuclear cells from tuberculosis patients.
Cadranel J; Philippe C; Perez J; Milleron B; Akoun G; Ardaillou R; Baud L
Clin Exp Immunol; 1990 Aug; 81(2):319-24. PubMed ID: 2387094
[TBL] [Abstract][Full Text] [Related]
15. Cytokine responses during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Production of Th1 and Th2 cytokines and relative contribution of tumor necrosis factor.
Chensue SW; Warmington K; Ruth J; Lincoln P; Kuo MC; Kunkel SL
Am J Pathol; 1994 Nov; 145(5):1105-13. PubMed ID: 7977642
[TBL] [Abstract][Full Text] [Related]
16. Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis.
Moreira AL; Tsenova-Berkova L; Wang J; Laochumroonvorapong P; Freeman S; Freedman VH; Kaplan G
Tuber Lung Dis; 1997; 78(1):47-55. PubMed ID: 9666962
[TBL] [Abstract][Full Text] [Related]
17. Anticytokine approaches to the treatment of anorexia and cachexia.
Haslett PA
Semin Oncol; 1998 Apr; 25(2 Suppl 6):53-7. PubMed ID: 9625384
[TBL] [Abstract][Full Text] [Related]
18. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment.
Sahiratmadja E; Alisjahbana B; de Boer T; Adnan I; Maya A; Danusantoso H; Nelwan RH; Marzuki S; van der Meer JW; van Crevel R; van de Vosse E; Ottenhoff TH
Infect Immun; 2007 Feb; 75(2):820-9. PubMed ID: 17145950
[TBL] [Abstract][Full Text] [Related]
19. A double-blind placebo-controlled phase II trial of thalidomide in asymptomatic HIV-positive patients: clinical tolerance and effect on activation markers and cytokines.
Marriott JB; Cookson S; Carlin E; Youle M; Hawkins DA; Nelson M; Pearson M; Vaughan AN; Gazzard B; Dalgleish AG
AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1625-31. PubMed ID: 9430254
[TBL] [Abstract][Full Text] [Related]
20. Modulation of LPS-, PHA- and M. tuberculosis-mediated cytokine production by pentoxifylline and thalidomide.
van Crevel R; Vonk AG; Netea MG; Kullberg BJ; van der Meer JW
Eur Cytokine Netw; 2000 Dec; 11(4):574-9. PubMed ID: 11125299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
